The single nucleotide variant at c.662A>G in human RRM2B is a loss-of-function mutation.

Abstract

Listen

Translate article

BackgroundMitochondrial DNA maintenance defects (MDMDs) is one of the critical pediatric dysfunction. One of the recent report indicated that a severe patient of MDMDs carries the NP_056528.2:p.Asn221Ser (N221S) variation in the RRM2B gene (NM_015713.5). However, there is no direct evidence demonstrating the nature of the N221S variation.Materials and MethodsThis study aimed to utilize zebrafish and morpholino oligomer (MO) knockdown technique to provide direct evidence for the nature of the N221S variation in the RRM2B.ResultsThe results showed that two distinct MOs were both able to perturb the expression of rrm2b in zebrafish and dose‐dependently induced morphological defects. Furthermore, co‐injection of human wild‐type RRM2B mRNA with MO‐e4i4 successfully rescued the developmental defects, whereas co‐injection of RRM2B/N221S mRNA with MO‐e4i4 did not rescue the developmental defects.ConclusionIn conclusion, the functional assay in this study provided the direct evidence proving that the N221S variation is a loss‐of‐function mutation and plausibly related to the pathogenic developmental defects found in the infants of previous clinical reports.